Receptors Flashcards

1
Q

Partial agonist?

A

Binds and activates receptor. Partial efficacy compared to a full agonist even at maximal receptor occupancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inverse agonist?

A

Bonds to same receptor site as agonist.
Inhibits constitutive activity of receptor.
Exerts opposite response to agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prerequisite for inverse agonist?

A

The receptor must have a constitutive activity in the absence of an agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Potency of agonist?

A

Half the maximal effective concentration of agonist- EC(50)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Relationship of EC(50) and potency?

A

The smaller the EC(50) the more potent the agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the 4 receptor types

A

LGIC
GPCR
single transmembrane receptor
Intercellular receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is the margin of safety of a drug evaluated?

A

By the therapeutic index.
TC(50)/EC(50
The bigger the better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Difference between drug specificity and selectivity?

A

Drug selectivity:
Drug has greater affinity for one receptor over another.
Other receptor still has some binding and activity.

Drug specificity:
No increase in drug can activate the other receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What types of LGICs are there?

A

Pentameric
Tetrameric
Trimeric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give examples of pentameric LGICs.

A

Nicotinic ACh
GABA (A)
Glycine
Serotonin (3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give an example of a tetrameric LGIC

A

Glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give an example of a Trimeric LGIC

A

ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How many transmembrane helices are in a GPCR?

A

7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where is the N terminus and C terminus positioned on a GPCR?

A

N terminus is extracellular

C terminus is intercellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How much time does it take to activate a LGIC

A

Less than one millisecond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How much time does it take to activate a GPCR?

A

Seconds to minutes

17
Q

4 types of G proteins

18
Q

What does Gs do?

A

Stimulates AC

19
Q

What does Gi do?

A

Inhibits AC

20
Q

What does Go do?

A

Stimulate PLC-beta

21
Q

What does Gq do?

A

Stimulate PLC-beta

22
Q

What’s a full agonist?

A

A ligand which binds and activates a receptor, producing maximal efficacy at that receptor

23
Q

What are the key events in tyrosine kinase activation?

A

Ligand binds to extracellular receptor domain
2 receptors dimerise
A conformational change of the intracellular kinase domains renders the active sites available for autophosphorylation by ATP

24
Q

Where in the cell are steroid receptors found?

A

In the cytosol

25
What macromolecule do steroids activate?
DNA
26
Where is the dose response curve of a ligand more potent than another?
Closer to zero on the x axis
27
What's different about the dose response curve of a ligand with a greater efficacy than another?
It is longer on the y axis
28
How does the Castillo & Katz mechanism explain how a partial agonist operates?
It shows that a ligand can be bound to a receptor without it activating it.
29
If the efficacy at a receptor is 1, what is the efficacy of an antagonist at that receptor?
The efficacy of an antagonist is always 0.
30
What is the pA(2) of an antagonist?
It's the antagonist potency | =-logK(b) for a competitive antagonist
31
How is the pA(2) evaluated?
Does not depend on K(A) Increases linearly with x(B) Slope of plot of (r(A)-1) against x(B) is 1/K(B) Relationships independent of agonist characteristics Should be the same for all agonists on the same population of receptors